A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and obesity or overweight used it ...

Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 ...

Tirzepatide and semaglutide are type 2 diabetes drugs often used for weight loss. Tirzepatide is less expensive and may be more effective. However, the drug is still new, and more research is needed.

Obstructive sleep apnea is characterized by disordered breathing during sleep and is associated with major cardiovascular complications; excess adiposity is an etiologic risk factor. Tirzepatide may ...

New study results found weight loss and diabetes drugs Zepbound and Mounjaro may significantly cut the risk of diabetes in people with prediabetes and obesity, adding to the growing list of diseases ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth. The ...

Eli Lilly’s weight loss injection tirzepatide — the ingredient inside its wildly popular drugs Mounjaro and Zepbound — could also help treat sleep apnea, according to research published Friday, a ...

Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity ...

Aug 1 (Reuters) - Trial results show Eli Lilly's (LLY.N), opens new tab weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

Ozempic has become a household name, its earworm of an ad jingle imprinted in our brains. And yet many of us still don’t know how the “miracle” weight-loss med (and its cohort, which includes Wegovy, ...